Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
1384
mi
from
Portland, OR
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
1384
mi
from
Portland, OR
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
1223
mi
from
Philadelphia, PA
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
974
mi
from
Pittsburgh, PA
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
478
mi
from
Memphis, TN
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
478
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
478
mi
from
Memphis, TN
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
478
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
340
mi
from
Dallas, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
340
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
340
mi
from
Dallas, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
340
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
348
mi
from
Fort Worth, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
348
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
572
mi
from
Houston, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
572
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
572
mi
from
Houston, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
572
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
572
mi
from
Houston, TX
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
572
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
777
mi
from
Salt Lake City, UT
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
1113
mi
from
Richmond, VA
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated:  9/3/2015
632
mi
from
Milwaukee, WI
Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
An Open-label, Multi-center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects With Confirmed Influenza Infection
Status: Enrolling
Updated: 9/3/2015
GSK Investigational Site
632
mi
from
Milwaukee, WI
Click here to add this to my saved trials
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Population
Status: Enrolling
Updated:  9/6/2015
1286
mi
from
New York, NY
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Population
Status: Enrolling
Updated: 9/6/2015
Columbia University Medical Center
1286
mi
from
New York, NY
Click here to add this to my saved trials
Influenza Vaccine in Premature Infants
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated:  9/15/2015
1319
mi
from
Miami, FL
Influenza Vaccine in Premature Infants
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
University of Miami
1319
mi
from
Miami, FL
Click here to add this to my saved trials
Influenza Vaccine in Premature Infants
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated:  9/15/2015
1056
mi
from
Buffalo, NY
Influenza Vaccine in Premature Infants
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
State University of New York at Buffalo
1056
mi
from
Buffalo, NY
Click here to add this to my saved trials
Influenza Vaccine in Premature Infants
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated:  9/15/2015
1121
mi
from
Rochester, NY
Influenza Vaccine in Premature Infants
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
University of Rochester
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
Influenza Vaccine in Premature Infants
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated:  9/15/2015
974
mi
from
Winston-Salem, NC
Influenza Vaccine in Premature Infants
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
Wake Forest University
974
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Influenza Vaccine in Premature Infants
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated:  9/15/2015
349
mi
from
Dallas, TX
Influenza Vaccine in Premature Infants
Influenza Vaccine Immunogenicity in Extremely Premature Infants
Status: Enrolling
Updated: 9/15/2015
University of Texas Southwestern Medical Center
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (2014-2015 Formulation)
Status: Enrolling
Updated:  9/16/2015
673
mi
from
Bardstown, KY
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (2014-2015 Formulation)
Status: Enrolling
Updated: 9/16/2015
Clinical Research Facility
673
mi
from
Bardstown, KY
Click here to add this to my saved trials
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (2014-2015 Formulation)
Status: Enrolling
Updated:  9/16/2015
779
mi
from
Salt Lake City, UT
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine (2014-2015 Formulation)
Status: Enrolling
Updated: 9/16/2015
Clinical Research Facility
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated:  9/16/2015
1348
mi
from
Santa Rosa, CA
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Clinical Research Facility
1348
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated:  9/16/2015
263
mi
from
Council Bluffs, IA
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Clinical Research Facility
263
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated:  9/16/2015
690
mi
from
Metairie, LA
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Clinical Research Facility
690
mi
from
Metairie, LA
Click here to add this to my saved trials
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated:  9/16/2015
726
mi
from
Cincinnati, OH
Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines, 2014-2015 Formulations
Status: Enrolling
Updated: 9/16/2015
Clinical Research Facility
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People
Evaluation of Anti-Hemagglutinin Antibodies as a Correlate of Protection in an H1N1 Influenza Healthy Human Challenge Model
Status: Enrolling
Updated:  9/17/2015
1123
mi
from
Bethesda, MD
Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People
Evaluation of Anti-Hemagglutinin Antibodies as a Correlate of Protection in an H1N1 Influenza Healthy Human Challenge Model
Status: Enrolling
Updated: 9/17/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
1168
mi
from
Los Angeles, CA
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
1039
mi
from
Boise, ID
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
1039
mi
from
Boise, ID
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
418
mi
from
Saint Louis, MO
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
418
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
1195
mi
from
Binghamton, NY
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
1195
mi
from
Binghamton, NY
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
1051
mi
from
Durham, NC
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
1051
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
1064
mi
from
Raleigh, NC
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
1064
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
976
mi
from
Winston-Salem, NC
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
976
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
1064
mi
from
Charleston, SC
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
1064
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
522
mi
from
Austin, TX
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
522
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
346
mi
from
Fort Worth, TX
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
346
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated:  9/20/2015
459
mi
from
San Angelo, TX
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
A Phase IV, Multicenter, Randomized, Observer-blind, Parallel-arm Study to Evaluate the Safety and Tolerability of CSL's Trivalent Influenza Virus Vaccine (CSL TIV) in Children 5 to Less Than 9 Years of Age.
Status: Enrolling
Updated: 9/20/2015
Clinical Research Facility
459
mi
from
San Angelo, TX
Click here to add this to my saved trials
Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children
Evaluation of the Effect of Age and Prior Immunity on the Response to Live or Inactivated A/California/07/09 H1N1 Influenza Vaccines in Children
Status: Enrolling
Updated:  9/22/2015
1121
mi
from
Rochester, NY
Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children
Evaluation of the Effect of Age and Prior Immunity on the Response to Live or Inactivated A/California/07/09 H1N1 Influenza Vaccines in Children
Status: Enrolling
Updated: 9/22/2015
University of Rochester Medical Center, Vaccine Research Unit Room 3-5000
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent Virus-like-particle (VLP) Influenza Vaccine in Adults
Status: Enrolling
Updated:  9/24/2015
1322
mi
from
Miami, FL
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent Virus-like-particle (VLP) Influenza Vaccine in Adults
Status: Enrolling
Updated: 9/24/2015
Miami Research Associates
1322
mi
from
Miami, FL
Click here to add this to my saved trials
Alternative Oseltamivir Dosing Strategies
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated:  9/26/2015
1177
mi
from
Los Angeles, CA
Alternative Oseltamivir Dosing Strategies
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
VA Greater Los Angeles Healthcare System
1177
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Alternative Oseltamivir Dosing Strategies
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated:  9/26/2015
1329
mi
from
Palo Alto, CA
Alternative Oseltamivir Dosing Strategies
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
VA Palo Alto Health Care System
1329
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Alternative Oseltamivir Dosing Strategies
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated:  9/26/2015
1123
mi
from
Bethesda, MD
Alternative Oseltamivir Dosing Strategies
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Alternative Oseltamivir Dosing Strategies
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated:  9/26/2015
573
mi
from
Houston, TX
Alternative Oseltamivir Dosing Strategies
Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis
Status: Enrolling
Updated: 9/26/2015
Brooke Army Medical Center
573
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy
A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy
Status: Enrolling
Updated:  9/28/2015
971
mi
from
Pittsburgh, PA
A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy
A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy
Status: Enrolling
Updated: 9/28/2015
Magee-Womens Hospital - University of Pittsburgh Medical Center
971
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated:  9/29/2015
1317
mi
from
Walnut creek, CA
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
Diablo Clinical Research Inc
1317
mi
from
Walnut creek, CA
Click here to add this to my saved trials
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated:  9/29/2015
1322
mi
from
Miami, FL
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
Miami Research Associates
1322
mi
from
Miami, FL
Click here to add this to my saved trials
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated:  9/29/2015
1050
mi
from
Meridian, ID
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
Advanced Clinical Research, Inc.
1050
mi
from
Meridian, ID
Click here to add this to my saved trials
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated:  9/29/2015
1189
mi
from
Endwell, NY
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
Regional Clinical Research, Inc.
1189
mi
from
Endwell, NY
Click here to add this to my saved trials
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated:  9/29/2015
1067
mi
from
Mt. Pleasant, SC
A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant
A Phase I/II Randomized, Observer-Blinded, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Monovalent A/Anhui/1/13 (H7N9) Virus-Like Particle (VLP) Avian Influenza Antigen (Recombinant) in Healthy Adults With and Without Matrix-M1™
Status: Enrolling
Updated: 9/29/2015
Coastal Carolina Research
1067
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials